Background: Neurofibromatosis type 1 (NF1) is an autosomal-dominant neurocutaneous disorder with an estimated prevalence of two to three cases per 10 000 population. While the physical characteristics have been well documented, speech disorders have not been fully characterized in NF1 patients. Aims: This study serves as a pilot to identify key…

This book contains contributions by scholars working on diverse aspects of speech who bring their findings to bear on the practical issue of how to treat stuttering in different language groups and in multilingual speakers. The book considers classic issues in speech production research, as well as whether regions of the brain that are affected in…

A panel of speech professionals was randomly presented with speech samples from four neurogenic and four developmental stutterers and was asked to classify them accordingly without any patient knowledge. Results support the view that, based on the patient's verbal output only, it is difficult to distinguish between neurogenic and developmental…

A survey of 128 females (ages 2-58) with Turner syndrome found almost one quarter were receiving or had received treatment for stuttering, articulation problems, and/or delayed language development, with the latter two disorders being checked most frequently. Only 4 or the 68 individuals receiving growth hormone treatment reported voice changes.…